The U.S. Food and Drug Administration (FDA) has designated Ibex Medical Analytics' Galen artificial intelligence (AI) software for pathology image analysis as a breakthrough device. The designation is granted to technologies with the potential to better diagnose cancer.
The AI-powered software supports pathologists in the detection of various types of cancer. Galen aims to reduce diagnosis time and boost productivity.
